Liane Teplitsky

COO

Equibles does not estimate personal net worth.

Get an email with a short summary when Pulse Biosciences, Inc. publishes a filing, an earnings call transcript or a press release.

Get PLSE alerts

About Liane Teplitsky

Liane Teplitsky is recorded as COO at Pulse Biosciences, Inc. (PLSE) since April 9, 2026. Pulse Biosciences, Inc. reported in an 8-K filed April 9, 2026 that Liane Teplitsky was appointed Chief Operating Officer. Pulse Biosciences, Inc. is classified in the Medical Instruments & Supplies industry within the Healthcare sector. Other leadership on record at Pulse Biosciences, Inc. includes Burke T. Barrett (CEO and Board Member), Kevin Danahy (CEO), Paul A. LaViolette (CEO, Chairman and Board Member) and 7 others.

“Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of nPulse™ technology using proprietary nanosecond pulsed field ablation (nsPFA™) energy, today announced the strengthening of its executive leadership team with the appointment of Liane Teplitsky as Chief Operating Officer and expanded role of Dr. David Kenigsberg as full-time Chief Medical Officer.”

Pulse Biosciences, Inc. Form 8-K, filed April 9, 2026 · Read the filing

Affiliation history

Pulse Biosciences, Inc. (PLSE)
COO

SEC 8-K

Current
2026-04-09–present

Company network

Pulse Biosciences, Inc.

PLSE

Current role

Medical Instruments & Supplies · Healthcare

COO

2026-04-09–present

Leadership on record at Pulse Biosciences, Inc.

Burke T. Barrett CEO, Board Member
Kevin Danahy CEO
Paul A. LaViolette CEO, Chairman, Board Member
Paul LaViolette CEO, Board Member
Robert W. Duggan Chairman, Board Member
Brian B. Dow CFO
Liane R. Teplitsky COO
Darrin R. Uecker CTO, Board Member
Darrin Uecker CTO
Steven T. Weber Chief Accounting Officer

Recent activity

Executive change Appointed: Chief Operating Officer Pulse Biosciences, Inc. (PLSE)
2026-04-09